Acrivon Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Acrivon Therapeutics, Inc.
CIK #0001781174
EDGAR Form CIK 2011 - 2025
10-K [0001781174]
10-Q [0001781174]
3 [0001781174]
4 [0001781174]
8-K [0001781174]
D [0001781174]
SC 13D [0001781174]
SC 13G [0001781174]
Form 13D/13G Filer Form 13D/13G Subject Filed
Marshall Wace North America LP Acrivon Therapeutics Inc [2023-02-14]
Chione Ltd Acrivon Therapeutics Inc [2022-11-28]
RA Capital Management LP Acrivon Therapeutics Inc [2022-11-28]
Sands Capital Life Sciences Pulse Fund II LP Acrivon Therapeutics Inc [2022-11-25]
Citadel Advisors LLC Acrivon Therapeutics Inc [2022-11-21]
Perceptive Advisors LLC Acrivon Therapeutics Inc [2022-11-18]
Form 3/4/5 Subject 2011 - 2025
Gamelin Erick
Acrivon Therapeutics, Inc.
Masson Kristina
Blume-Jensen Peter
Devroe Eric
Peterson Katharine
Miller Mary
Levy Adam D.
Palani Santhosh
RA Capital Management LP
View All
Terms | Privacy | Guide
tony@aum13f.com